DV
Dividend Vision

ADIA — Adia Nutrition Inc

Adia Nutrition Inc (ADIA)

Total return is -25.0% over the past 22.4 years, 992.5 points behind SPY at 967.5%. Its deepest 1-year drawdown was 73.4%.

Adia Med Inc offers medical treatments and nutritional supplements through three operating segments: Biolete, Adia Med, and Adia Labs. The company provides autologous hematopoietic stem cell transplantation (AHSCT) treatments for multiple sclerosis patients, operates a clinic performing stem cell treatments, and procures and sells stem cell products to outside clinics as well as directly to consumers. Distribution information is not currently available.

ADIA key facts

Asset type
Stock
Asset class
Equity
Inception date
03/23/2004
Distribution frequency
None
Last close
$0.12
Market cap
$11,328,563
Average volume
39800.0
Beta
-8.226
Payout ratio
0.0
P/E ratio
0.0
Forward P/E
0.0
EPS
$0.00